Taysha Gene Therapies
Price & Volume
Stats
See more52W Range | $1.05-$3.40 |
Market Cap | $796.5M |
Shares Short | 40M |
Financials
See moreRevenue (12 Mos) | $8M |
Revenue Growth (YoY) | 78.6% |
Gross Profit (12 Mos) | $8M |
Diluted EPS | -$0.34 |
News
See moreYahoo Finance • 19 days ago
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Earnings call transcript: Taysha Gene's Q2 2025 revenue beats forecast
Yahoo Finance • last month
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Mr. Sean P. Nolan |
CFO | Mr. Kamran Alam CPA, M.B.A. |
Address | 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 73 |
